Literature DB >> 998249

The localization of precancerous changes and carcinoma after previous gastric operation for benign condition.

E Hammar.   

Abstract

Sixty-five patients operated on for a benign gastric condition showed at re-operation in 9 cases precancerous changes, in 22 cases carcinoma in situ, and in 34 cases infiltrating carcinoma. The median time to elapse between the two operations was 20 years. The pathological diagnosis established at the first operation was most often benign duodenal ulcer. Investigation revealed in 9 cases precancerous changes and in 47 cases various grades of adenocarcinoma within the anastomosis. In 37 cases of Billroth II operations, 5 precancerous changes, 15 carcinomas in situ and 17 infiltrative cancers were located on the posterior gastric wall near the efferent small intestinal loop. In these cases there were additional changes, one precancerous, 7 carcinomas in situ and two infiltrating cancers, situated against the cephalic part of the afferent small intestinal loop. Nineteen Billroth II patients had precancers or cancers at other sites within the anastomosis or gastric remnant. The remaining 9 cases of Billroth I, gastro-enterostomy and gastric Roux-en-Y procedures are too few to allow conclusions concerning the localization of precancer or cancer in the anastomosis.

Entities:  

Mesh:

Year:  1976        PMID: 998249     DOI: 10.1111/j.1699-0463.1976.tb00147.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Scand A        ISSN: 0365-4184


  2 in total

1.  A case report: carcinoma of the gastric stump after Billroth II resection.

Authors:  S K Chang; H C Kim; J H Ahn; Y S Kim; S M Park; C S Kim; S J Park; S I Park; S T Chang; Y W Park
Journal:  Korean J Intern Med       Date:  1988-01       Impact factor: 2.884

Review 2.  Role of New Anatomy, Biliopancreatic Reflux, and Helicobacter Pylori Status in Postgastrectomy Stump Cancer.

Authors:  Luigi Basso; Gaetano Gallo; Daniele Biacchi; Maria Vittoria Carati; Giuseppe Cavallaro; Luca Esposito; Andrea Giuliani; Luciano Izzo; Paolo Izzo; Antonietta Lamazza; Andrea Polistena; Mariarita Tarallo; Alessandro Micarelli; Enrico Fiori
Journal:  J Clin Med       Date:  2022-03-09       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.